MANUKA TREASURE
DEAD

Serial Number

88978568

Owner

JT's Global Trading USA Inc

Attorney

David L. Sigalow

Filing Date

Jan 2, 2020

Add to watchlist:

No watchlists yet
View on USPTO

MANUKA TREASURE Trademark

Serial Number: 88978568

MANUKA TREASURE is a trademark filed by JT's Global Trading USA Inc on January 2, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 30 (Staple Foods). The application is currently no longer active.

Owner Contact Info

JT's Global Trading USA Inc (2 trademarks)

Cheyenne, WY 82001

Entity Type: 03

Trademark Details

Filing Date

January 2, 2020

Registration Date

Not Registered

Goods & Services

Honey; propolis for human consumption royal jelly for human consumption not for medical purposes, namely, royal jelly for food purposes; honey-based confectionery, namely, toffees, chocolates and flavored ices; breakfast cereals made from wheat, oats, rice and all including honey; honey-based dressings for salads; honey-based sauces for salads, meats and desserts, all made from or including honey, propolis, royal jelly and pollen; with all of the aforementioned goods being made from, or including manuka honey or ingredients derived from the manuka tree

Therapeutic and dietary preparations containing pollen, honey and/or other bee products, namely, therapeutic medicated bath preparations and dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; vitamin and mineral supplements made from or containing royal jelly, propolis, pollen, beeswax, and/or honey; pharmaceutical preparations, namely, antimicrobial agents for treating wounds, oral applications for preventing viruses and internal applications for preventing infection, all made from or containing honey, pollen, collodion, propolis, royal jelly, bee venom and/or beeswax; pharmaceutical preparations, namely, antiseptic agents for treating wounds, oral applications for preventing viruses and internal applications for preventing infection, all made from or containing honey, pollen, collodion, propolis, royal jelly, bee venom and/or beeswax; gauze for dressings, adhesive plasters for medical purposes, bandages for dressings, antiseptic medical and surgical dressings, antiseptic medical bandages for dressings and surgical bandages, antiseptic medical and surgical gauzes, tissues, namely, pre-moistened medicated tissues for wounds, all impregnated or coated with pharmaceutical lotions made from or including royal jelly, pollen, beeswax and/or honey; pharmaceutical preparations for skin care made from or including royal jelly, pollen, beeswax, and/or honey; teas, namely, antimicrobial and antiseptic medicinal teas for therapeutic, medicinal and dental purposes for internal application made from or including honey, propolis, royal jelly, pollen, bee venom and/or beeswax; antimicrobial and antiseptic medicinal drinks, dietetic infusions for medical use and tonics in the nature of medicinal drinks for therapeutic, medicinal and dental purposes for internal application, all made from or including honey, propolis, royal jelly, pollen, bee venom and/or beeswax; antimicrobial and antiseptic pastilles for therapeutic, medicinal and dental purposes, namely, cough pastilles for medical use, mouth cavity cleansers, and mouthwashes for medical purposes, all for internal application made from or including honey, propolis, royal jelly, pollen, bee venom and/or beeswax; antimicrobial and antiseptic tablets for therapeutic, medicinal and dental purposes, namely, antibiotic tablets, allergy tablets and vitamin tablets, all for internal application made from or including honey, propolis; royal jelly, pollen, bee venom and/or beeswax; topical medicated skin lotions, gels and ointments for pharmaceutical and veterinary purposes, namely, topical medicated skin lotion, topical first aid gel, medicated diaper rash ointment and medicated sunburn ointments, all made from or including royal jelly, propolis, pollen, beeswax and/or honey; topical medicated ointments for pharmaceutical and veterinary purposes, namely mercurial ointments for medical use made from or including royal jelly, propolis, pollen, beeswax and/or honey; with all of the aforementioned goods being made from, or including manuka honey or ingredients derived from the manuka tree

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Sep 5, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sep 5, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 22, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 22, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 22, 2025 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 27, 2025 RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 8, 2024 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 16, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 10, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 5, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 4, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 2, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 1, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 26, 2021 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 22, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 22, 2020 GNSL
SUSPENSION LETTER WRITTEN
Oct 22, 2020 CNSL
ASSIGNED TO EXAMINER
Oct 22, 2020 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 25, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 25, 2020 TROA
ASSIGNED TO EXAMINER
Aug 18, 2020 DOCK
DIVISIONAL PROCESSING COMPLETE
Aug 18, 2020 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 17, 2020 AITU
DIVISIONAL REQUEST RECEIVED
Jun 23, 2020 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Jun 23, 2020 ERTD
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 30, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 30, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 30, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 24, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 9, 2020 NWOS
NEW APPLICATION ENTERED
Jan 6, 2020 NWAP